First Subject Recruited for Early-Phase Clinical Trial

Jun 30, 2022 at 4:27 AM UTC · Issued by Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd has released a press release.